Announcements

Conference: The 146th Annual Meeting of the Pharmaceutical Society of Japan (Osaka)
Date: 26–29 March 2026
Location: Osaka, Japan

MDPI will be attending the 146th Annual Meeting of the Pharmaceutical Society of Japan (Osaka) as an exhibitor, which will be held from 26 to 29 March 2026, and we welcome researchers from diverse backgrounds to visit and share their latest ideas with us.

Pharmaceutical sciences are comprehensive sciences that require expertise from a wide range of academic fields, including physics, chemistry, biology, medical sciences, and clinical sciences. In order to overcome the various challenges surrounding pharmaceutical sciences today, cross-disciplinary collaboration beyond traditional boundaries has become increasingly important and will be emphasized and discussed during the 146th Annual Meeting of the Pharmaceutical Society of Japan (Osaka).

The conference is organized by the Pharmaceutical Society of Japan and chaired by Prof. Takashi Ohshima from the Graduate School of Pharmaceutical Sciences, Kyushu University. The theme is Promoting the Ecosystem in Pharmaceutical Sciences: Future Innovation through Cross-disciplinary Collaboration. This conference will bring together around 5,000 scientists and students to share research advances covering a wide range of scientific topics. The sessions include, but are not limited to, the following: (1) Pharmaceutical Chemistry; (2) Pharmaceutical Physics; (3) Pharmaceutical Biology; (4) Pharmaceutical Health Science and Environmental Toxicology; (5) Pharmaceutical Health Care and Sciences; and (6) Others.

The following MDPI journals will be represented at the conference:

• Pharmaceuticals;
• Diseases;
• Pharmacy;
• Applied Biosciences;
• Antibodies;
• Biomedicines;
• Future Pharmacology;
• JPBI;
• JPM;
• Marine Drugs;
• Medicines;
• Pharmaceutics;
• Pharmacoepidemiology.

Conference: 5th MMCS: New Trends in Chemical Biology and Drug Discovery
Date: 14–17 May 2026, Beijing Time
Conference website: https://sciforum.net/event/MMCS2026

This conference is organized by the MDPI journal Molecules (ISSN: 1420-3049, IF: 4.2, and CiteScore: 7.4) and will take place in Beijing, China, from 14 to 17 May 2026 (Beijing time).

Conference Chairs:

• Prof. Dr. Xiaoguang Lei, College of Chemistry and Molecular Engineering, Peking University, China;
• Prof. Dr. Diego Muñoz-Torrero, Faculty of Pharmacy and Food Sciences, and Institute of Biomedicine (IBUB), University of Barcelona, Spain.

Topics of interest:
S1. Chemical biology for drug discovery;
S2. AI for drug discovery;
S3. New proximity-based drug modalities;
S4. Natural products in drug discovery;
S5. Biocatalysis for natural product and drug synthesis;
S6. Drug discovery targeting GPCRs and ion channels;
S7. DNA-encoded libraries in drug discovery;
S8. Medicinal chemistry tales.

Important dates:
Deadline for abstract submission: 16 January 2026;
Abstract acceptance notification: 9 February 2026;
Early bird registration deadline: 11 February 2026;
Covering author registration deadline: 11 February 2026;
Registration deadline: 14 May 2026.

Guide for authors:

To submit your abstract, please visit the following link: https://sciforum.net/user/submission/create/1319.

To register for the event, please visit the following link: https://sciforum.net/event/MMCS2026?section=#registration.

For more information, you may refer to the following link: https://sciforum.net/event/MMCS2026.

For any inquiries regarding the event, please contact mmcs2026@mdpi.com.

We look forward to seeing you at the 5th MMCS: New Trends in Chemical Biology and Drug Discovery.

MDPI is delighted to announce the establishment of the Michele Parrinello Award. Named in honor of Professor Michele Parrinello, the award celebrates his exceptional contributions and his profound impact on the field of computational physical science research.

The award will be presented biennially to distinguished scientists who have made outstanding achievements and contributions in the field of computational physical science—spanning physics, chemistry, and materials science.

About Professor Michele Parrinello

"Do not be afraid of new things. I see it many times when we discuss a new thing that young people are scared to go against the mainstream a little bit, thinking what is going to happen to me and so on. Be confident that what you do is meaningful, and do not be afraid, do not listen too much to what other people have to say.”

——Professor Michele Parrinello

Born in Messina in 1945, he received his degree from the University of Bologna and is currently affiliated with the Italian Institute of Technology. Professor Parrinello is known for his many technical innovations in the field of atomistic simulations and for a wealth of interdisciplinary applications ranging from materials science to chemistry and biology. Together with Roberto Car, he introduced ab initio molecular dynamics, also known as the Car–Parrinello method, marking the beginning of a new era both in the area of electronic structure calculations and in molecular dynamics simulations. He is also known for the Parrinello–Rahman method, which allows crystalline phase transitions to be studied by molecular dynamics. More recently, he has introduced metadynamics for the study of rare events and the calculation of free energies.

For his work, he has been awarded many prizes and honorary degrees. He is a member of numerous academies and learned societies, including the German Berlin-Brandenburgische Akademie der Wissenschaften, the British Royal Society, and the Italian Accademia Nazionale dei Lincei, which is the major academy in his home country of Italy.

Award Committee

The award committee will be chaired by Professor Xin-Gao Gong, a computational condensed matter physicist, academician of the Chinese Academy of Sciences, and professor at the Department of Physics, Fudan University. Professor Xin-Gao Gong will lead a panel of several senior experts in the field to oversee the evaluation and selection process. The Institute for Computational Physical Sciences at Fudan University (Shanghai, China), led by Professor Xin-Gao Gong, will serve as the supporting institute for the award.

"We hope the Michele Parrinello Award will recognize scientists who have made significant contributions to the field of computational condensed matter physics and at the same time set a benchmark for the younger generation, providing clear direction for their pursuit—this is precisely the original intention behind establishing the award."

——Professor Xin-Gao Gong

The first edition of the award was officially launched on 1 November 2025. Nominations will be accepted before the end of March 2026. For further details, please visit mparrinelloaward.org.

About the MDPI Sustainability Foundation and MDPI Awards

The Michele Parrinello Award is part of the MDPI Sustainability Foundation, which is dedicated to advancing sustainable development through scientific progress and global collaboration. The foundation also oversees the World Sustainability Award, the Emerging Sustainability Leader Award, and the Tu Youyou Award. The establishment of the Michele Parrinello Award will further enrich the existing award portfolio, providing continued and diversified financial support to outstanding professionals across various fields. 

In addition to these foundation-level awards, MDPI journals also recognize outstanding contributions through a range of honors, including Best Paper Awards, Outstanding Reviewer Awards, Young Investigator Awards, Travel Awards, Best PhD Thesis Awards, Editor of Distinction Awards, and others. These initiatives aim to recognize excellence across disciplines and career stages, contributing to the long-term vitality and sustainability of scientific research.

Find more information on awards here.

We are honored to recognize the 2024 MDPI Top 1000 Reviewers—scholars whose exemplary commitment to rigorous and constructive peer review is vital in upholding the highest standards of academic publishing.

Selected from a distinguished pool of 215,000 reviewers from 65 countries and regions worldwide, these honorees stand out for their exceptional expertise, diligence, and dedication to advancing research through timely and thoughtful reviews. Their constructive and impartial feedback ensures the publication of high-quality, impactful research, while their timely reviews facilitate swift revisions and faster publication of innovative work.

Peer review is the invisible foundation of academic progress. With gratitude and respect, we celebrate these 1000 scholars who made that foundation stronger in 2024. We respected all privacy preferences, with part of nominees opting for limited attribution.

The names of these reviewers are listed below in alphabetical order by first name:

We are pleased to announce updates to our article template, aimed at improving the readability and visual appeal of our publications. The following updates will be applied to articles published in volumes in 2026, starting from 19 December 2025.

Left information bar:

• Updated the logo and URL for “Check for updates”;
• Removed the “Citation” section (Note: Citation details remain accessible via “Cite” in the online article version);
• Changed the link in “Copyright” to a hyperlink format.

Footer:

• Added a DOI link at the bottom-right corner of each page.

The updated template is now available for download from the Instructions for Authors page of each journal.

We hope that the new version of the template will provide users with better experience and make the process more convenient.

For any questions or suggestions, please contact our production team at production@mdpi.com.

We are pleased to announce the selection of the Editor’s Choice Articles published in Biomedicines (ISSN: 2227-9059, latest Impact Factor 3.9, CiteScore 6.8) in the “Gene and Cell Therapy” Section. All of these papers have been selected by the Editorial Board Members from 2023 to 2024 and have been positively received by researchers; therefore, it is believed that they will interest readers and provide opportunities for follow-up research.

1. “SERPINA3: Stimulator or Inhibitor of Pathological Changes”
by Mateusz de Mezer, Jan Rogaliński, Stanisław Przewoźny, Michał Chojnicki, Leszek Niepolski, Magdalena Sobieska and Agnieszka Przystańska
Biomedicines 2023, 11(1), 156; https://doi.org/10.3390/biomedicines11010156
Available online: https://www.mdpi.com/2227-9059/11/1/156

2. “Adipose Tissue and Adipose-Tissue-Derived Cell Therapies for the Treatment of the Face and Hands of Patients Suffering from Systemic Sclerosis”
by Anouck Coulange Zavarro, Mélanie Velier, Robin Arcani, Maxime Abellan Lopez, Stéphanie Simoncini, Audrey Benyamine, Quentin Gomes De Pinho, Raphael Coatmeur, Jiucun Wang, Jingjing Xia et al.
Biomedicines 2023, 11(2), 348; https://doi.org/10.3390/biomedicines11020348
Available online: https://www.mdpi.com/2227-9059/11/2/348

3. “The Role of COX-2 and PGE2 in the Regulation of Immunomodulation and Other Functions of Mesenchymal Stromal Cells”
by Agnieszka Kulesza, Agnieszka Kulesza and Anna Burdzinska
Biomedicines 2023, 11(2), 445; https://doi.org/10.3390/biomedicines11020445
Available online: https://www.mdpi.com/2227-9059/11/2/445

4. “3D Spheroid Cultivation Alters the Extent and Progression of Osteogenic Differentiation of Mesenchymal Stem/Stromal Cells Compared to 2D Cultivation”
by Anne Wolff, Marcus Frank, Susanne Staehlke, Armin Springer, Olga Hahn, Juliane Meyer and Kirsten Peters
Biomedicines 2023, 11(4), 1049; https://doi.org/10.3390/biomedicines11041049
Available online: https://www.mdpi.com/2227-9059/11/4/1049

5. “Identifying Potent Nonsense-Mediated mRNA Decay Inhibitors with a Novel Screening System”
by Julie Carrard, Fiona Ratajczak, Joséphine Elsens, Catherine Leroy, Rebekah Kong, Lucie Geoffroy, Arnaud Comte, Guy Fournet, Benoît Joseph, Xiubin Li et al.
Biomedicines 2023, 11(10), 2801; https://doi.org/10.3390/biomedicines11102801
Available online: https://www.mdpi.com/2227-9059/11/10/2801

6. “Suppressing Pro-Apoptotic Proteins by siRNA in Corneal Endothelial Cells Protects against Cell Death”
by Susanne Staehlke, Siddharth Mahajan, Daniel Thieme, Peter Trosan and Thomas A Fuchsluger
Biomedicines 2024, 12(7), 1439; https://doi.org/10.3390/biomedicines12071439
Available online: https://www.mdpi.com/2227-9059/12/7/1439

7. “Restoration of T and B Cell Differentiation after RAG1 Gene Transfer in Human RAG1 Defective Hematopoietic Stem Cells”
by Nataël Sorel, Francisco Díaz-Pascual, Boris Bessot, Hanem Sadek, Chloé Mollet, Myriam Chouteau, Marco Zahn, Irene Gil-Farina, Parisa Tajer, Marja van Eggermond et al.
Biomedicines 2024, 12(7), 1495; https://doi.org/10.3390/biomedicines12071495
Available online: https://www.mdpi.com/2227-9059/12/7/1495

8. “Cell-Based Treatment in Acute Myeloid Leukemia Relapsed after Allogeneic Stem Cell Transplantation”
by Martina Canichella and Paolo de Fabritiis
Biomedicines 2024, 12(8), 1721; https://doi.org/10.3390/biomedicines12081721
Available online: https://www.mdpi.com/2227-9059/12/8/1721

9. “Updates on Chimeric Antigen Receptor T-Cells in Large B-Cell Lymphoma”
by Khalil Saleh, Nadine Khalife, Ahmadreza Arbab, Rita Khoury, Claude Chahine, Rebecca Ibrahim, Zamzam Tikriti, Nohad Masri, Mohamad Hachem and Axel Le Cesne
Biomedicines 2024, 12(12), 2810; https://doi.org/10.3390/biomedicines12122810
Available online: https://www.mdpi.com/2227-9059/12/12/2810

To acknowledge the above authors’ excellent contribution, we are happy to provide a full waiver to each team of the above publications. We also would like to take this opportunity to thank all the research groups that have submitted to Biomedicines. We would appreciate it if you would circulate this document among your colleagues and network. Furthermore, the following opportunities for collaboration may be of interest to you:
 
Submitting a manuscript:
The “Gene and Cell Therapy” Section is currently open for submissions. Papers may be submitted via the following link: https://www.mdpi.com/user/manuscripts/upload/?journal=biomedicines.

Joining the Volunteer Reviewer Board:
If you are an active researcher in the fields of biomedicincal research and are interested in joining the Volunteer Reviewer Board of Biomedicines, please do not hesitate to submit your application via the following link: https://susy.mdpi.com/volunteer/profile/edit.

Biomedicines Editorial Office

We are pleased to announce the selection of the Editor’s Choice Articles published in Biomedicines (ISSN: 2227-9059, latest Impact Factor 3.9, CiteScore 6.8) in the “Endocrinology and Metabolism Research” Section. All of these papers have been selected by the Editorial Board Members from 2023 to 2024 and have been positively received by researchers; therefore, it is believed that they will interest readers and provide opportunities for follow-up research.

1. “The Role of Adipokines in Health and Disease”
by Vicente Javier Clemente-Suárez, Laura Redondo-Flórez, Ana Isabel Beltrán-Velasco, Alexandra Martín-Rodríguez, Ismael Martínez-Guardado, Eduardo Navarro-Jiménez, Carmen Cecilia Laborde-Cárdenas and José Francisco Tornero-Aguilera
Biomedicines 2023, 11(5), 1290; https://doi.org/10.3390/biomedicines11051290
Available online: https://www.mdpi.com/2227-9059/11/5/1290

2. “Estrogens in Adipose Tissue Physiology and Obesity-Related Dysfunction”
by Alina Kuryłowicz
Biomedicines 2023, 11(3), 690; https://doi.org/10.3390/biomedicines11030690
Available online: https://www.mdpi.com/2227-9059/11/3/690

3. “The Relationship between Type 1 Diabetes Mellitus, TNF-α, and IL-10 Gene Expression”
by Jesselina Francisco dos Santos Haber, Sandra Maria Barbalho, Jose Augusto Sgarbi, Rafael Santos de Argollo Haber, Roger William de Labio, Lucas Fornari Laurindo, Eduardo Federighi Baisi Chagas and Spencer Luiz Marques Payão
Biomedicines 2023, 11(4), 1120; https://doi.org/10.3390/biomedicines11041120
Available online: https://www.mdpi.com/2227-9059/11/4/1120

4. “Adipokines as Clinically Relevant Therapeutic Targets in Obesity”
by Marleen Würfel, Matthias Blüher, Michael Stumvoll, Thomas Ebert, Peter Kovacs, Anke Tönjes and Jana Breitfeld
Biomedicines 2023, 11(5), 1427; https://doi.org/10.3390/biomedicines11051427
Available online: https://www.mdpi.com/2227-9059/11/5/1427

5. “Non-Alcoholic Fatty Liver Disease or Type 2 Diabetes Mellitus—The Chicken or the Egg Dilemma”
by Marcin Kosmalski, Agnieszka Śliwińska and Józef Drzewoski
Biomedicines 2023, 11(4), 1097; https://doi.org/10.3390/biomedicines11041097
Available online: https://www.mdpi.com/2227-9059/11/4/1097

6. “Genetic Insights into Age-Related Macular Degeneration”
by Bhumika, Nalini S. Bora and Puran S. Bora
Biomedicines 2024, 12(7), 1479; https://doi.org/10.3390/biomedicines12071479
Available online: https://www.mdpi.com/2227-9059/12/7/1479

7. “The Role of GLP-1, GIP, MCP-1 and IGFBP-7 Biomarkers in the Development of Metabolic Disorders: A Review and Predictive Analysis in the Context of Diabetes and Obesity”
by Malwina Jędrysik, Krzysztof Wyszomirski, Anna Różańska-Walędziak, Emilia Grosicka-Maciąg, Maciej Walędziak and Beata Chełstowska
Biomedicines 2024, 12(1), 159; https://doi.org/10.3390/biomedicines12010159
Available online: https://www.mdpi.com/2227-9059/12/1/159

8. “Impact of SGLT2 Inhibitors on Very Elderly Population with Heart Failure with Reduce Ejection Fraction: Real Life Data”
by Jorge Balaguer Germán, Marcelino Cortés García, Carlos Rodríguez López, Jose María Romero Otero, Jose Antonio Esteban Chapel, Antonio José Bollas Becerra, Luis Nieto Roca, Mikel Taibo Urquía, Ana María Pello Lázaro and José Tuñón Fernández
Biomedicines 2024, 12(7), 1507; https://doi.org/10.3390/biomedicines12071507
Available online: https://www.mdpi.com/2227-9059/12/7/1507

9. “Age-Related Decline in Gangliosides GM1 and GD1a in Non-CNS Tissues of Normal Mice: Implications for Peripheral Symptoms of Parkinson’s Disease”
by Suman Chowdhury, Gusheng Wu, Zi-Hua Lu, Ranjeet Kumar and Robert Ledeen
Biomedicines 2023, 11(1), 209; https://doi.org/10.3390/biomedicines11010209
Available online: https://www.mdpi.com/2227-9059/11/1/209

10. “The Multifaceted Nature of Macrophages in Cardiovascular Disease”
by Cindy X. Li and Lixia Yue
Biomedicines 2024, 12(6), 1317; https://doi.org/10.3390/biomedicines12061317
Available online: https://www.mdpi.com/2227-9059/12/6/1317

The following opportunities for collaboration may be of interest to you:

Submitting a manuscript:
The “Endocrinology and Metabolism Research” Section is currently open for submissions. Papers may be submitted via the following link: https://www.mdpi.com/user/manuscripts/upload/?journal=biomedicines.

Joining the Volunteer Reviewer Board:
If you are an active researcher in the fields of biomedical research and are interested in joining the Volunteer Reviewer Board of Biomedicines, please do not hesitate to submit your application via the following link: https://susy.mdpi.com/volunteer/profile/edit.

Biomedicines Editorial Office

We are pleased to announce the selection of The Editor’s Choice Articles published in Biomedicines (ISSN: 2227-9059, latest Impact Factor 3.9, CiteScore 6.8) in the “Drug Discovery, Development and Delivery” Section. All of these papers are from 2023 to 2024 and have been selected by the Editorial Board Members and have been positively received by researchers; therefore, it is believed that they will interest readers and provide opportunities for follow-up research.

1. “Seventy Years of Antipsychotic Development: A Critical Review”
by Mujeeb U. Shad
Biomedicines 2023, 11(1), 130; https://doi.org/10.3390/biomedicines11010130
Available online: https://www.mdpi.com/2227-9059/11/1/130

2. “DNA Gyrase as a Target for Quinolones”
by Angela C. Spencer and Siva S. Panda
Biomedicines 2023, 11(2), 371; https://doi.org/10.3390/biomedicines11020371
Available online: https://www.mdpi.com/2227-9059/11/2/371

3. “Advancing Medicine with Lipid-Based Nanosystems—The Successful Case of Liposomes”
by Hugo Luiz. Jacinta Oliveira Pinho and Maria Manuela Gaspar
Biomedicines 2023, 11(2), 435; https://doi.org/10.3390/biomedicines11020435
Available online: https://www.mdpi.com/2227-9059/11/2/435

4. “Anti-Inflammatory Therapeutic Mechanisms of Natural Products: Insight from Rosemary Diterpenes, Carnosic Acid and Carnosol”
by Solomon Habtemariam
Biomedicines 2023, 11(2), 545; https://doi.org/10.3390/biomedicines11020545
Available online: https://www.mdpi.com/2227-9059/11/2/545

5. “G-Quadruplexes in c-MYC Promoter as Targets for Cancer Therapy”
by Bárbara Bahls, Israa M. Aljnadi, Rita Emídio, Eduarda Mendes and Alexandra Paulo
Biomedicines 2023, 11(3), 969; https://doi.org/10.3390/biomedicines11030969
Available online: https://www.mdpi.com/2227-9059/11/3/969

6. “Pathogenesis, Intervention, and Current Status of Drug Development for Sarcopenia: A Review”
by Jung Yoon Jang, Donghwan Kim and Nam Deuk Kim
Biomedicines 2023, 11(6), 1635; https://doi.org/10.3390/biomedicines11061635
Available online: https://www.mdpi.com/2227-9059/11/6/1635

7. “Aptamer-Based Smart Targeting and Spatial Trigger–Response Drug-Delivery Systems for Anticancer Therapy”
by Dongsik Park, Su Jin Lee and Jee-Woong Park
Biomedicines 2024, 12(1), 187; https://doi.org/10.3390/biomedicines12010187
Available online: https://www.mdpi.com/2227-9059/12/1/187

8. “Broad Epitope Coverage of Therapeutic Multi-Antibody Combinations Targeting SARS-CoV-2 Boosts In Vivo Protection and Neutralization Potency to Corner an Immune-Evading Virus”
by Ilse Roodink, Maartje van Erp, Andra Li, Sheila Potter, Sander M. J. van Duijnhoven, Milou Smits, Arthur J. Kuipers, Bert Kazemier, Bob Berkeveld, Ellen van Geffen et al.
Biomedicines 2024, 12(3), 642; https://doi.org/10.3390/biomedicines12030642
Available online: https://www.mdpi.com/2227-9059/12/3/642

9. “Repurposing of the Cardiovascular Drug Statin for the Treatment of Cancers: Efficacy of Statin–Dipyridamole Combination Treatment in Melanoma Cell Lines”
by Nanami Irie, Kana Mizoguchi, Tomoko Warita, Mirai Nakano, Kasuga Sasaki, Jiro Tashiro, Tomohiro Osaki, Takuro Ishikawa, Zoltán N. Oltvai and Katsuhiko Warita
Biomedicines 2024, 12(3), 698; https://doi.org/10.3390/biomedicines12030698
Available online: https://www.mdpi.com/2227-9059/12/3/698

10. “Novel Therapeutics for Type 2 Diabetes Mellitus—A Look at the Past Decade and a Glimpse into the Future”
by Ying Jie Chee and Rinkoo Dalan
Biomedicines 2024, 12(7), 1386; https://doi.org/10.3390/biomedicines12071386
Available online: https://www.mdpi.com/2227-9059/12/7/1386

The following opportunities for collaboration may be of interest to you:

Submitting a manuscript:
The “Drug Discovery, Development and Delivery” Section is currently open for submissions. Papers may be submitted via the following link: https://susy.mdpi.com/user/submit_manuscript/bd2cec81fecc6d4aa0cb88423924b5bc/1?journal=biomedicines.

Joining the Volunteer Reviewer Board:
If you are an active researcher in the fields of biomedical research and are interested in joining the Volunteer Reviewer Board of Biomedicines, please do not hesitate to submit your application via the following link: https://susy.mdpi.com/volunteer/profile/edit.

Biomedicines Editorial Office

We are pleased to announce the selection of Editor’s Choice Articles published in Biomedicines (ISSN: 2227-9059, latest Impact Factor 3.9, CiteScore 6.8) in the “Cell Biology and Pathology” Section. All of these papers have been selected from 2023 to 2024 by the Editorial Board Members and have been positively received by researchers; therefore, we believe that they will interest readers and provide opportunities for follow-up research.

1. “Efficient Liposome Loading onto Surface of Mesenchymal Stem Cells via Electrostatic Interactions for Tumor-Targeted Drug Delivery”
by Yusuke Kono, Renpei Kamino, Soma Hirabayashi, Takuya Kishimoto, Himi Kanbara, Saki Danjo,
Mika Hosokawa and Ken-ichi Ogawara
Biomedicines 2023, 11(2), 558; https://doi.org/10.3390/biomedicines11020558
Available online: https://www.mdpi.com/2227-9059/11/2/558

2. “MicroRNA Signatures in Cartilage Ageing and Osteoarthritis”
by Panagiotis Balaskas, Katarzyna Goljanek-Whysall, Peter D. Clegg, Yongxiang Fang, Andy Cremers, Aibek Smagul, Tim J. M. Welting and Mandy J. Peffers
Biomedicines 2023, 11(4), 1189; https://doi.org/10.3390/biomedicines11041189
Available online: https://www.mdpi.com/2227-9059/11/4/1189

3. “MRI Methods to Visualize and Quantify Adipose Tissue in Health and Disease”
by Katerina Nikiforaki and Kostas Marias
Biomedicines 2023, 11(12), 3179; https://doi.org/10.3390/biomedicines11123179
Available online: https://www.mdpi.com/2227-9059/11/12/3179

4. “Wnt Signaling in Atherosclerosis: Mechanisms to Therapeutic Implications”
by Rizwana Afroz and Julie E. Goodwin
Biomedicines 2024, 12(2), 276; https://doi.org/10.3390/biomedicines12020276
Available online: https://www.mdpi.com/2227-9059/12/2/276

5. “100 Years since the Discovery of Insulin, from Its Discovery to the Insulins of the Future”
by Carmen Lambert and Elias Delgado
Biomedicines 2024, 12(3), 533; https://doi.org/10.3390/biomedicines12030533
Available online: https://www.mdpi.com/2227-9059/12/3/533

6. “The Role of Lipoprotein(a) in Peripheral Artery Disease”
by Nicholas Pavlatos and Dinesh K. Kalra
Biomedicines 2024, 12(6), 1229; https://doi.org/10.3390/biomedicines12061229
Available online: https://www.mdpi.com/2227-9059/12/6/1229

7. “CBP/P300 Inhibition Impairs CD4+ T Cell Activation: Implications for Autoimmune Disorders”
by Lucas Wilhelmus Picavet, Anoushka A. K. Samat, Jorg Calis, Lotte Nijhuis, Rianne Scholman, Michal Mokry, David F. Tough, Rabinder K. Prinjha, Sebastiaan J. Vastert and Jorg van Loosdregt
Biomedicines 2024, 12(6), 1344; https://doi.org/10.3390/biomedicines12061344
Available online: https://www.mdpi.com/2227-9059/12/6/1344

8. “p53 Genetics and Biology in Lung Carcinomas: Insights, Implications and Clinical Applications”
by Dixan A. Benitez, Guadalupe Cumplido-Laso, Marcos Olivera-Gómez, Nuria Del Valle-Del Pino, Alba Díaz-Pizarro, Sonia Mulero-Navarro, Angel Román-García and Jose Maria Carvajal-Gonzalez
Biomedicines 2024, 12(7), 1453; https://doi.org/10.3390/biomedicines12071453
Available online: https://www.mdpi.com/2227-9059/12/7/1453

9. “The Placenta as a Source of Human Material for Neuronal Repair”
by Alessia Dallatana, Linda Cremonesi, Francesco Pezzini, Gianluca Fontana, Giulio Innamorati and Luca Giacomello
Biomedicines 2024, 12(7), 1567; https://doi.org/10.3390/biomedicines12071567
Available online: https://www.mdpi.com/2227-9059/12/7/1567

10. “Succinate Dehydrogenase and Human Disease: Novel Insights into a Well-Known Enzyme”
by María J. Esteban-Amo, Patricia Jiménez-Cuadrado, Pablo Serrano-Lorenzo, Miguel Á. de la Fuente and María Simarro
Biomedicines 2024, 12(9), 2050; https://doi.org/10.3390/biomedicines12092050
Available online: https://www.mdpi.com/2227-9059/12/9/2050

Furthermore, the following opportunities for collaboration may be of interest to you:

Submitting a manuscript:
This “Cell Biology and Pathology” Section is currently open for submissions. Papers may be submitted via the following link: https://www.mdpi.com/user/manuscripts/upload/?journal=biomedicines.

Joining the Volunteer Reviewer Board:
If you are an active researcher in the fields of biomedical research and are interested in joining the Volunteer Reviewer Board of Biomedicines, please do not hesitate to submit your application via the following link: https://susy.mdpi.com/volunteer/profile/edit.

Biomedicines Editorial Office

We are pleased to announce the selection of Editor’s Choice Articles published in Biomedicines (ISSN: 2227-9059, latest Impact Factor 3.9, CiteScore 6.8) in the “Cancer Biology and Oncology” Section. All of these papers have been selected from 2023 to 2024 by the Editorial Board Members and have been positively received by researchers; therefore, we believe that they will interest readers and provide opportunities for follow-up research.

1. “Eph Receptors in Cancer”
by Sakshi Arora, Andrew M. Scott and Peter W. Janes
Biomedicines 2023, 11(2), 315; https://doi.org/10.3390/biomedicines11020315
Available online: https://www.mdpi.com/2227-9059/11/2/315

2. “Pancreatic Cancer Organoids: An Emerging Platform for Precision Medicine?”
by Evangelia Sereti, Irida Papapostolou and Konstantinos Dimas
Biomedicines 2023, 11(3), 890; https://doi.org/10.3390/biomedicines11030890
Available online: https://www.mdpi.com/2227-9059/11/3/890

3. “Targeting PI3K/AKT/mTOR Pathway in Breast Cancer: From Biology to Clinical Challenges”
by Krisida Cerma, Federico Piacentini, Luca Moscetti, Monica Barbolini, Fabio Canino, Antonio Tornincasa, Federica Caggia, Sara Cerri, Alessia Molinaro, Massimo Dominici et al.
Biomedicines 2023, 11(1), 109; https://doi.org/10.3390/biomedicines11010109
Available online: https://www.mdpi.com/2227-9059/11/1/109

4. “Mint3 as a Potential Target for Cooling Down HIF-1α-Mediated Inflammation and Cancer Aggressiveness”
by Noritaka Tanaka and Takeharu Sakamoto
Biomedicines 2023, 11(2), 549; https://doi.org/10.3390/biomedicines11020549
Available online: https://www.mdpi.com/2227-9059/11/2/549

5. “Mesenchymal Stem Cell-Derived Exosomes Modulate Angiogenesis in Gastric Cancer”
by Fawzy Akad, Veronica Mocanu, Sorin Nicolae Peiu, Viorel Scripcariu, Bogdan Filip, Daniel Timofte, Florin Zugun-Eloae, Magdalena Cuciureanu, Monica Hancianu, Teodor Oboroceanu et al.
Biomedicines 2023, 11(4), 1031; https://doi.org/10.3390/biomedicines11041031
Available online: https://www.mdpi.com/2227-9059/11/4/1031

6. “Exploring the Use of Cold Atmospheric Plasma to Overcome Drug Resistance in Cancer”
by Dzohara Murillo, Carmen Huergo, Borja Gallego, René Rodríguez and Juan Tornín
Biomedicines 2023, 11(1), 208; https://doi.org/10.3390/biomedicines11010208
Available online: https://www.mdpi.com/2227-9059/11/1/208

7. “Amino Acid Deprivation in Glioblastoma: The Role in Survival and the Tumour Microenvironment—A Narrative Review”
by Keven Du, Leila Grocott, Giulio Anichini, Kevin O’Neill and Nelofer Syed
Biomedicines 2024, 12(11), 2481; https://doi.org/10.3390/biomedicines12112481
Available online: https://www.mdpi.com/2227-9059/12/11/2481

8. “Targeted Therapy Development in Acute Myeloid Leukemia”
by Tulasigeri M. Totiger, Anirban Ghoshal, Jenna Zabroski, Anya Sondhi, Saanvi Bucha, Jacob Jahn, Yangbo Feng and Justin Taylor
Biomedicines 2023, 11(2), 641; https://doi.org/10.3390/biomedicines11020641
Available online: https://www.mdpi.com/2227-9059/11/2/641

9. “The Biological Clock of Liver Metabolism in Metabolic Dysfunction-Associated Steatohepatitis Progression to Hepatocellular Carcinoma”
by Pradeep Kumar Rajan, Utibe-Abasi S. Udoh, Robert Finley, Sandrine V. Pierre and Juan Sanabria
Biomedicines 2024, 12(9), 1961; https://doi.org/10.3390/biomedicines12091961
Available online: https://www.mdpi.com/2227-9059/12/9/1961

10. “Investigation of High Frequency Irreversible Electroporation for Canine Spontaneous Primary Lung Tumor Ablation”
by Alayna N. Hay, Kenneth N. Aycock, Melvin F. Lorenzo, Kailee David, Sheryl Coutermarsh-Ott, Zaid Salameh, Sabrina N. Campelo, Julio P. Arroyo, Brittany Ciepluch, Gregory Daniel et al.
Biomedicines 2024, 12(9), 2038; https://doi.org/10.3390/biomedicines12092038
Available online: https://www.mdpi.com/2227-9059/12/9/2038

Furthermore, the following opportunities for collaboration may be of interest to you:

Submitting a manuscript:
This “Cancer Biology and Oncology” Section is currently open for submissions. Papers may be submitted via the following link: https://www.mdpi.com/user/manuscripts/upload/?journal=biomedicines.

Joining the Volunteer Reviewer Board:
If you are an active researcher in the fields of biomedical research and are interested in joining the Volunteer Reviewer Board of Biomedicines, please do not hesitate to submit your application via the following link: https://susy.mdpi.com/volunteer/profile/edit.